Unintended Consequences: Understanding the Fallout of the IRA on Government Payor Programs and the Private Sector

March 20, 2024 1:45pm

Merle DeLancey
Partner
Blank Rome LLP

James Kim
Partner
Arnold & Porter

  • Analyzing the consequences of the IRA on other government drug payor programs:
    • Medicaid
    • PHS 340B
    • VA and DOD
  • Understanding what the implications of the IRA are on the supply chain that inevitably affects cost and pricing
  • Delving into how the private sector will be (or is) handling the IRA implementation
    • Exploring how the price of drugs will vary
    • Consequences for Medicare Advantage plans
  • How will IRA- mandated pricing changes trickle through and affect the market to affect drug valuations as well as the economy